Ladislav Chrobák
-
Successful Treatment of Iron Overload with Phlebotomies in Two Siblings with Congenital Dyserythropoietic Anemia – Type II (CDA-II)
Ladislav Chrobák
2006, Vol. 49, Issue 3, pp. 193-195 -
Excess of Pappenheimer Bodies (Siderocytes) in Two Splenectomized Siblings with Congenital Dyserythropoietic Anemia – Type II (CDA-II) and Iron Overload
Ladislav Chrobák, Jindřiška Matysová
2004, Vol. 47, Issue 3, pp. 187-188 -
Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
Ladislav Chrobák, Jaroslava Voglová
2003, Vol. 46, Issue 3, pp. 85-89 -
Paroxysmal Nocturnal Hemoglobinuria (Membrane Defect, Pathogenesis, Aplastic Anemia, Diagnosis)
Ladislav Chrobák
2000, Vol. 43, Issue 1, pp. 3-8 -
Is Factor V Leiden a Risk Factor for Fetal Loss?
Petr Dulíček, Ladislav Chrobák, Ivo Kalousek, Lenka Pešavová, Miroslav Pecka, Pravoslav Stránský
1999, Vol. 42, Issue 3, pp. 93-96 -
Minimal Residual Disease, Its Detection and Significance in Hairy-Cell Leukemia
Pavel Žák, Ladislav Chrobák, Karel Dědič
1999, Vol. 42, Issue 3, pp. 85-88 -
History of Hematology at the Charles University, Faculty of Medicine and Faculty Hospital in Hradec Králové
Ladislav Chrobák, Milan Bláha
1998, Vol. 41, Issue 3, pp. 145-153 -
Red Cell Distribution Width (RDW) as a Marker of Disease Activity in Patients with Hairy Cell Leukemia
Ladislav Chrobák, Pavel Žák, Karel Podzimek, Pravoslav Stránský
1998, Vol. 41, Issue 1, pp. 23-26 -
Long-Term Results in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine
Ladislav Chrobák, Pavel Žák, Karel Podzimek, Lenka Plíšková, Jaroslava Foglová, Vladimír Maisnar, Petr Dulíček, Karel Dědič
1997, Vol. 40, Issue 2, pp. 41-45
